Skip to main content

Advertisement

Log in

Design, synthesis and cytotoxic activity of novel 1-aroyl-4-(2-chloroethyl)semicarbazides

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Abstract

A series of aroyl derivatives of 4-(2-chloroethyl)semicarbazide were designed and synthesized to explore their antiproliferative activity against human brain carcinoma (U251) and human liver carcinoma (Hepg2) cell lines. The synthesized compounds were characterized by elemental analyses and spectroscopic data. It was established that compounds in which semicarbazide fragments are substituted with a (2-indolyl)carbonyl moiety showed a higher cytotoxic activity than the corresponding benzoyl derivatives. 1-[(5-Benzyloxy-1H-indol-2-yl)carbonyl]-4-(2-chloroethyl)semicarbazide (24) showed the highest cytotoxic activity against Hepg2 (IC50= 21 µg/ml), while 4-(2-chloroethyl)-1-[(5-methoxy-1H-indol-2-yl)carbonyl]semicarbazide (23) was the most active compound against U251 (IC50 = 8 µg/ml).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. P. Luis and D. Ross, Cancer Chemotherapy and Biotherapy: Principles and Practice, Lippincott Williams and Wilkins, New York (2002), p. 315.

    Google Scholar 

  2. L. Thelander and P. Reichard, Ann. Rev. Biochem., 48, 133 (1979).

    Article  PubMed  CAS  Google Scholar 

  3. V. DeVita, P. Crabone, and A. Owens, Cancer. Res., 25, 1876 (1965).

    CAS  Google Scholar 

  4. F. Schabel, T. Johnston, and G. McCaleb, Cancer. Res., 23, 226 (1963).

    Google Scholar 

  5. D. Ludlum, Mutat. Res., 233, 117 (1990).

    PubMed  CAS  Google Scholar 

  6. M. Dolan, R. Moschel, and A. Pegg, Proc. Natl. Acad. Sci., 87, 5368 (1990).

    Article  PubMed  CAS  Google Scholar 

  7. L. Limbird, A. Gilman, and J. Hardman, The Pharmacological Basis of Therapeutics, McGraw-Hill, New Work (1996), p. 1236.

    Google Scholar 

  8. R. Gaudreault, J. Lacroix, M. Page, and P. Joly, J. Pharm. Sci., 77, 185 (1988).

    Article  PubMed  CAS  Google Scholar 

  9. J. Lacroix, R. Gaudreault, M. Page, and P. Joly, Anticancer. Res., 8, 595 (1988).

    PubMed  CAS  Google Scholar 

  10. E. Petitclerc, G. Réna, C. Marquis, et al., Cancer. Res., 64, 4654 (2004).

    Article  PubMed  CAS  Google Scholar 

  11. R. Gaudreault, M. Alaoui, G. Batist, et al., Cancer. Chemother. Pharmacol., 33, 479 (1994).

    Google Scholar 

  12. E. Mounetou, J. Legault, J. Lacroix, and R. Gaudreault, J. Med. Chem., 44, 694 (2001).

    Article  PubMed  CAS  Google Scholar 

  13. J. Legault, J. Gaulin, E. Mounetou, et al., Cancer. Res., 60, 985 (2000).

    PubMed  CAS  Google Scholar 

  14. G. Bacher, T. Beckers, P. Emig, et al., Pure. Appl. Chem., 37, 1459 (2001).

    Article  Google Scholar 

  15. V. Gorbinov, A. Kost, and R. Sagitullin, Pharm. Chem. J., 9, 12 (1968) [Chem Abstr., 70, 19856a (1969)].

    Google Scholar 

  16. P. Skehan, R. Storeng, D. Scudiero, et al., J. Natl. Cancer. Inst., 82, 1107 (1990).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 41, No. 4, pp. 12–15, May, 2007.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Sadek, M.E., Aboukull, M.E., El-Sabbagh, O.I. et al. Design, synthesis and cytotoxic activity of novel 1-aroyl-4-(2-chloroethyl)semicarbazides. Pharm Chem J 41, 188–192 (2007). https://doi.org/10.1007/s11094-007-0043-0

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-007-0043-0

Keywords

Navigation